[40] compared the genes of patients with early stage Oestrogen Receptor (ER)‐positive breast cancer who did not have recurrence of breast cancer after tamoxifen treatment with those of patients with recurrent breast cancer, and found that there was a significant difference in the expression of CHDH. Here, CHDH is linked to breast carcinoma.